The discovery, published today in Nature Communications by researchers from La Trobe University and the University of Queensland, provides details on how proteins in the outer membrane of bacteria -- the bacteria's 'superglue' -- are able to stick to and populate parts of the human body.
This new information paves the way for the development of innovative treatments for preventing and curing infections, in what could be a significant step forward for new anti-microbial development.
The study focused on UpaB - the superglue protein of a pathogen known to cause urinary tract infections within 50 percent of women within their lifetime.
Similar proteins are found in the outer membrane of other pathogens responsible for infections ranging from life-threatening food poisoning to whooping cough, meningitis, typhus fever and chlamydia.
Lead researcher at La Trobe University, Dr. Begoña Heras, said the study provides unprecedented fundamental science that could inform future solutions to the world health crisis in antibiotic resistance.
"The knowledge we now have on this bacteria's protein gives us the ability to block the bacteria sticking to different parts of the human body," said Dr Heras.
"Antibiotic resistance is an urgent, global problem and this information gives us an important opportunity to develop new anti-microbial treatments. Naturally, this is the next step for this research."
La Trobe researcher Dr. Jason Paxman added that there is a flip-side to these bacterial proteins in that they could be harnessed for good.
"There is nothing like these bacterial proteins in modern medicine; bacteria have had thousands of years to develop these adhesive proteins," Paxman explained. "These findings could open up new opportunities such as delivering targeted therapies to parts of the human body, which could even help in the fight against cancer down the line."
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.